Matsumura Y, Matsuo G, Egi Y, Tadano K, Morimoto S
Department of Pharmacology, Osaka University of Pharmaceutical Sciences, Japan.
J Cardiovasc Pharmacol. 1996 Aug;28(2):278-84. doi: 10.1097/00005344-199608000-00015.
The effects of endothelin-3 (ET-3) on changes in renal hemodynamics, urine formation, and norepinephrine (NE) overflow induced by renal nerve stimulation (RNS) were examined in anesthetized dogs. RNS at a low frequency (0.5-2.0 Hz) produced significant decreases in urine flow (UF), urinary excretion of sodium (UNaV), and fractional excretion of sodium (FENa), and increased the NE secretion rate (NESR) without affecting systemic or renal hemodynamics. RNS at a high frequency (2.5-5.0 Hz), which diminishes renal hemodynamics by causing renal vasoconstriction, affected urine formation and NESR more potently than did low-frequency RNS. When ET-3 (2.0 ng/kg/min) was infused into the renal artery, there was a slight and transient increase in renal blood flow (RBF); this response was followed by a gradual reduction. ET-3 infusion tended to increase the basal levels of UF without affecting UNaV, indicating the excretion of hypotonic urine with administration of this peptide. During ET-3 infusion, low-frequency RNS-induced antidiuretic action was significantly attenuated. Simultaneously, increase in NESR elicited by low-frequency RNS was markedly suppressed. Qualitatively similar results were observed in the case of high-frequency RNS. In addition, high-frequency RNS-induced decreases in the glomerular filtration rate (GFR) and the filtration fraction (FF) were suppressed by ET-3 infusion. These findings suggest that ET-3 suppresses renal responses to stimulated renal noradrenergic neurotransmission by inhibiting the release of NE. These findings, together with our previous findings, suggest that ET-3 (and/or ET-1) functions as an inhibitory modulator of the renal noradrenergic nervous system through the prejunctional ETB-receptor mechanism.
在麻醉犬中研究了内皮素 - 3(ET - 3)对肾血流动力学变化、尿液生成以及肾神经刺激(RNS)诱导的去甲肾上腺素(NE)溢出的影响。低频(0.5 - 2.0 Hz)的RNS使尿流量(UF)、尿钠排泄量(UNaV)和钠排泄分数(FENa)显著降低,并增加NE分泌率(NESR),而不影响全身或肾血流动力学。高频(2.5 - 5.0 Hz)的RNS通过引起肾血管收缩降低肾血流动力学,比低频RNS更有力地影响尿液生成和NESR。当将ET - 3(2.0 ng/kg/min)注入肾动脉时,肾血流量(RBF)有轻微且短暂的增加;此反应随后逐渐降低。ET - 3输注倾向于增加UF的基础水平,而不影响UNaV,表明给予该肽时排泄低渗尿。在ET - 3输注期间,低频RNS诱导的抗利尿作用显著减弱。同时,低频RNS引起的NESR增加被明显抑制。在高频RNS的情况下观察到定性相似的结果。此外,ET - 3输注抑制了高频RNS诱导的肾小球滤过率(GFR)和滤过分数(FF)的降低。这些发现表明,ET - 3通过抑制NE的释放来抑制肾对刺激的肾去甲肾上腺素能神经传递的反应。这些发现与我们之前的发现一起表明,ET - 3(和/或ET - 1)通过节前ETB受体机制作为肾去甲肾上腺素能神经系统的抑制性调节剂发挥作用。